{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:22:28Z","timestamp":1760523748225,"version":"3.37.3"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81500537"],"award-info":[{"award-number":["81500537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","amjmedsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of the Medical Sciences"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.amjms.2019.01.017","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T19:50:30Z","timestamp":1549050630000},"page":"311-315","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Soluble Vascular Cell Adhesion Molecule-1 Is Associated With Disease Activity in Adult-Onset Minimal Change Disease"],"prefix":"10.1016","volume":"357","author":[{"given":"Qingyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hengjin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianfeng","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yangyang","family":"Xia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuyuan","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunming","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjms.2019.01.017_bib0001","doi-asserted-by":"crossref","first-page":"e3179","DOI":"10.1097\/MD.0000000000003179","article-title":"Predictors of relapse in adult-onset nephrotic minimal change disease","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.amjms.2019.01.017_bib0002","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.05000516","article-title":"Minimal Change disease","volume":"12","author":"Vivarelli","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.amjms.2019.01.017_bib0003","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.amjms.2019.01.017_bib0004","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.mehy.2006.04.072","article-title":"The nephrotic syndrome is an immunoinflammatory disorder","volume":"68","author":"Camici","year":"2007","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.amjms.2019.01.017_bib0005","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ndt\/16.2.276","article-title":"Circulating soluble adhesion molecules in ANCA-associated vasculitis","volume":"16","author":"Ara","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.amjms.2019.01.017_bib0006","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/rheumatology\/33.12.1112","article-title":"Correlation of blood levels of soluble vascular cell adhesion molecule-1 with disease activity in systemic lupus erythematosus and vasculitis","volume":"33","author":"Janssen","year":"1994","journal-title":"Br J Rheumatol"},{"key":"10.1016\/j.amjms.2019.01.017_bib0007","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1177\/0961203314528061","article-title":"Cell adhesion molecules as potential biomarkers of nephritis, damage and accelerated atherosclerosis in patients with SLE","volume":"23","author":"Skeoch","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.amjms.2019.01.017_bib0008","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1053\/j.ajkd.2005.02.007","article-title":"Increased endothelin 1 expression in adult-onset minimal change nephropathy with acute renal failure","volume":"45","author":"Chen","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.amjms.2019.01.017_bib0009","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/8286067","article-title":"Serum soluble vascular cell adhesion molecule-1 overexpression is a disease marker in patients with first-time diagnosed antinuclear antibodies: a prospective, observational pilot study","volume":"2018","author":"Oleszowsky","year":"2018","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.amjms.2019.01.017_bib0010","first-page":"19","article-title":"Implication of soluble forms of cell adhesion molecules in infectious disease and tumor: insights from transgenic animal models","author":"Ono","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.amjms.2019.01.017_bib0011","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0049-0172(96)80034-5","article-title":"Adhesion Molecules in Autoimmune Disease","volume":"25","author":"McMurray","year":"1996","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.amjms.2019.01.017_bib0012","article-title":"The usefulness of endothelial cell adhesion molecules and anti-c1q antibody in monitoring systemic lupus erythematosus disease activity","volume":"2014","author":"Mahayidin","year":"2014","journal-title":"Int Sch Res Notices"},{"key":"10.1016\/j.amjms.2019.01.017_bib0013","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/adc.80.1.74","article-title":"Endothelial cell adhesion molecules in meningococcal disease","volume":"80","author":"Baines","year":"1999","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.amjms.2019.01.017_bib0014","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/0167-5699(93)90267-O","article-title":"Circulating adhesion molecules in disease","volume":"14","author":"Gearing","year":"1993","journal-title":"Immunol Today"},{"key":"10.1016\/j.amjms.2019.01.017_bib0015","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/qjmed\/hcg037","article-title":"Assessment of endothelial damage and dysfunction: observations in relation to heart failure","volume":"96","author":"Chong","year":"2003","journal-title":"QJM"},{"key":"10.1016\/j.amjms.2019.01.017_bib0016","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2005.12.030","article-title":"Circulating markers of endothelial function in cardiovascular disease","volume":"368","author":"Constans","year":"2006","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.amjms.2019.01.017_bib0017","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1191\/096120398678920172","article-title":"Relationship between lupus nephritis activity and the serum level of soluble VCAM-1","volume":"7","author":"Ikeda","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.amjms.2019.01.017_bib0018","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1365-2249.1994.tb06107.x","article-title":"Levels of soluble VCAM-1, soluble ICAM-1, and soluble E-selectin during disease exacerbations in patients with systemic lupus erythematosus (SLE); a long term prospective study","volume":"97","author":"Spronk","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.amjms.2019.01.017_bib0019","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1097\/00001721-200210000-00006","article-title":"Markers of endothelial cell injury and thrombin activatable fibrinolysis inhibitor in nephrotic syndrome","volume":"13","author":"Malyszko","year":"2002","journal-title":"Blood Coagul Fibrinolysis"},{"key":"10.1016\/j.amjms.2019.01.017_bib0020","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.thromres.2004.06.025","article-title":"Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?","volume":"115","author":"Malyszko","year":"2005","journal-title":"Thromb Res"},{"key":"10.1016\/j.amjms.2019.01.017_bib0021","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1440-1797.2012.01575.x","article-title":"Biomarkers of endothelial dysfunction in patients with primary focal segmental glomerulosclerosis","volume":"17","author":"Zhang","year":"2012","journal-title":"Nephrology (Carlton)"},{"key":"10.1016\/j.amjms.2019.01.017_bib0022","first-page":"809","article-title":"Serum ELAM-1 is increased in vasculitis, scleroderma, and systemic lupus erythematosus","volume":"20","author":"Carson","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1016\/j.amjms.2019.01.017_bib0023","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1136\/ard.58.3.189","article-title":"Circulating soluble adhesion molecules in patients with giant cell arteritis. Correlation between soluble intercellular adhesion molecule-1 (sICAM-1) concentrations and disease activity","volume":"58","author":"Coll-Vinent","year":"1999","journal-title":"Ann Rheum Dis"}],"container-title":["The American Journal of the Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962919300321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002962919300321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T17:40:12Z","timestamp":1565199612000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002962919300321"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S0002962919300321"],"URL":"https:\/\/doi.org\/10.1016\/j.amjms.2019.01.017","relation":{},"ISSN":["0002-9629"],"issn-type":[{"type":"print","value":"0002-9629"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soluble Vascular Cell Adhesion Molecule-1 Is Associated With Disease Activity in Adult-Onset Minimal Change Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of the Medical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjms.2019.01.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc. on behalf of Southern Society for Clinical Investigation.","name":"copyright","label":"Copyright"}]}}